Group One Trading, L.P. Sarepta Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 37,045 shares of SRPT stock, worth $4.23 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

37,045

Holding current value

$4.23 Million

% of portfolio

0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $4.61 Million - $5.81 Million	37,045 New	37,045 $4.63 Million
Q1 2024 May 10, 2024	SELL	$93.7 - $141.53 $10.6 Million - $16 Million	-112,967 Reduced 83.54%	22,262 $2.88 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $1.86 Million - $3.44 Million	-27,583 Reduced 16.94%	135,229 $13 Million
Q3 2023 Nov 09, 2023	SELL	$102.5 - $123.59 $516,190 - $622,399	-5,036 Reduced 3.0%	162,812 $19.7 Million
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $3.63 Million - $5.36 Million	-34,072 Reduced 16.87%	167,848 $19.2 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $21.3 Million - $28.3 Million	181,444 Added 886.13%	201,920 $27.8 Million
Q4 2022 Feb 09, 2023	BUY	$100.86 - $132.13 $432,891 - $567,101	4,292 Added 26.52%	20,476 $2.65 Million
Q3 2022 Nov 09, 2022	SELL	$75.71 - $119.24 $4.45 Million - $7 Million	-58,731 Reduced 78.4%	16,184 $1.79 Million
Q2 2022 Aug 11, 2022	BUY	$62.69 - $88.44 $4.7 Million - $6.63 Million	74,915 New	74,915 $5.62 Million
Q1 2022 May 12, 2022	SELL	$63.15 - $90.42 $7.27 Million - $10.4 Million	-115,055 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $340,263 - $437,746	4,403 Added 3.98%	115,055 $10.4 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $2.51 Million - $3.51 Million	37,993 Added 52.29%	110,652 $10.2 Million
Q2 2021 Aug 10, 2021	SELL	$69.38 - $86.75 $5.54 Million - $6.93 Million	-79,879 Reduced 52.37%	72,659 $5.65 Million
Q1 2021 May 12, 2021	BUY	$72.25 - $168.95 $6.08 Million - $14.2 Million	84,166 Added 123.1%	152,538 $11.4 Million
Q4 2020 Feb 10, 2021	BUY	$125.56 - $178.74 $5.13 Million - $7.3 Million	40,819 Added 148.15%	68,372 $11.7 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $3.5 Million - $4.75 Million	27,553 New	27,553 $3.87 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $3.4 Million - $6.27 Million	-36,542 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $2.89 Million - $4.61 Million	35,052 Added 2352.48%	36,542 $3.58 Million
Q4 2019 Feb 10, 2020	BUY	$76.53 - $135.58 $5,280 - $9,355	69 Added 4.86%	1,490 $192,000
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $103,463 - $222,969	1,421 New	1,421 $107,000
Q1 2018 May 11, 2018	SELL	$54.02 - $82.27 $3 Million - $4.56 Million	-55,446 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$47.64 - $56.75 $6.62 Million - $7.88 Million	-138,909 Reduced 71.47%	55,446 $3.09 Million
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $5.42 Million - $7.15 Million	151,573 Added 354.29%	194,355 $8.82 Million
Q2 2017 Aug 14, 2017	BUY	N/A	42,782	42,782 $1.44 Million

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Sarepta Therapeutics, Inc. Transaction History